{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T13:36:46Z","timestamp":1791293806571,"version":"4.1.0"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2003,10,1]],"date-time":"2003-10-01T00:00:00Z","timestamp":1064966400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Immunol"],"published-print":{"date-parts":[[2003,10]]},"DOI":"10.1038\/nri1204","type":"journal-article","created":{"date-parts":[[2003,10,1]],"date-time":"2003-10-01T18:52:27Z","timestamp":1065034347000},"page":"831-838","source":"Crossref","is-referenced-by-count":99,"title":["Individuality: the barrier to optimal immunosuppression"],"prefix":"10.1038","volume":"3","author":[{"given":"Barry D.","family":"Kahan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BFnri1204_CR1","volume-title":"De cortorum chirurgia","author":"G Tagliacozzi","year":"1597","unstructured":"Tagliacozzi, G. De cortorum chirurgia. (Venice: Bindoni) (1597)."},{"key":"BFnri1204_CR2","first-page":"311","volume":"21","author":"E Benjamin","year":"1908","unstructured":"Benjamin, E. & Sulka, E. Antik\u00f6rperbildung nach experimenteller schadgung des haematopoietischen systems durch r\u00f6ntgenstrahlen. Wien. Klin. Wochenschr. 21, 311\u2013314 (1908).","journal-title":"Wien. Klin. Wochenschr."},{"key":"BFnri1204_CR3","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1073\/pnas.1.7.435","volume":"1","author":"JB Murphy","year":"1915","unstructured":"Murphy, J. B. & Morton, J. J. The lymphocyte as a factor in natural and induced resistance to transplanted cancer. Proc. Natl Acad. Sci. USA 1, 435 (1915).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnri1204_CR4","first-page":"1771","volume":"67","author":"J Hamburger","year":"1959","unstructured":"Hamburger, J., Vayesse, J. & Crosnier, J. Transplantation of kidney between nonhomozygotic twins after irradiation of the recipient. Presse. Med. 67, 1771\u20131773 (1959).","journal-title":"Presse. Med."},{"key":"BFnri1204_CR5","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/BF01655296","volume":"10","author":"JA Myburgh","year":"1986","unstructured":"Myburgh, J. A. et al. Total lymphoid irradiation in renal transplantation. World J. Surg. 10, 369\u2013380 (1986).","journal-title":"World J. Surg."},{"key":"BFnri1204_CR6","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/S0140-6736(85)92624-8","volume":"2","author":"B Levin","year":"1985","unstructured":"Levin, B. et al. Treatment of cadaveric renal transplant recipients with total lymphoid irradiation, antithymocyte globulin, and low-dose prednisone. Lancet 2, 1321\u20131325 (1985).","journal-title":"Lancet"},{"key":"BFnri1204_CR7","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/infdis\/19.1.69","volume":"19","author":"L Hektoen","year":"1916","unstructured":"Hektoen, L. The effect of benzene on the production of antibodies. J. Infect. Dis. 19, 69 (1916).","journal-title":"J. Infect. Dis."},{"key":"BFnri1204_CR8","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1001\/archsurg.1952.01260020694008","volume":"65","author":"R Baker","year":"1952","unstructured":"Baker, R., Gordon, R., Huffer, J. & Miller, G. H. Jr. Experimental renal transplantation: I. Effect of nitrogen mustard, cortisone, and splenectomy. Arch Surg. 65, 702\u2013705 (1952).","journal-title":"Arch Surg."},{"key":"BFnri1204_CR9","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1038\/1831682a0","volume":"183","author":"RS Schwartz","year":"1959","unstructured":"Schwartz, R. S. & Dameshek, W. Drug-induced immunological tolerance. Nature 183, 1682 (1959).","journal-title":"Nature"},{"key":"BFnri1204_CR10","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1749-6632.1954.tb40008.x","volume":"60","author":"GH Hitchings","year":"1954","unstructured":"Hitchings, G. H. & Elion, G. B. The chemistry and biochemistry of purine analogs. Ann. NY Acad. Sci. 60, 195 (1954).","journal-title":"Ann. NY Acad. Sci."},{"key":"BFnri1204_CR11","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/j.1749-6632.1962.tb45358.x","volume":"99","author":"RY Calne","year":"1962","unstructured":"Calne, R. Y., Alexandre, G. P. & Murray, J. E. A study of the effects of drugs in prolonged survival of homologous renal transplantation in dogs. Ann. NY Acad. Sci. 99, 743 (1962).","journal-title":"Ann. NY Acad. Sci."},{"key":"BFnri1204_CR12","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1515\/CCLM.2003.087","volume":"41","author":"M Oscarson","year":"2003","unstructured":"Oscarson, M. Pharmacogenetics of drug metabolising enzymes: importance for personalised medicine. Clin. Chem. Lab. Med. 41, 573\u2013580 (2003).","journal-title":"Clin. Chem. Lab. Med."},{"key":"BFnri1204_CR13","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1097\/00007890-199806150-00007","volume":"65","author":"TH Matthew","year":"1998","unstructured":"Matthew, T. H. A blinded, long-term randomized, multicenter study of mycophenolate mofetil in cadaveric renal transplantation. Transplantation 65, 1450\u20131454 (1998).","journal-title":"Transplantation"},{"key":"BFnri1204_CR14","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1016\/S0041-1345(01)02378-8","volume":"33","author":"DK Granger","year":"2001","unstructured":"Granger, D. K. Enteric-coated mycophenolate sodium: results of two pivotal global multicenter trials. Transplant Proc. 33, 3241\u20133244 (2001).","journal-title":"Transplant Proc."},{"key":"BFnri1204_CR15","first-page":"385","volume":"117","author":"TE Starzl","year":"1963","unstructured":"Starzl, T. E., Marchioro, T. L. & Waddell, W. R. The reversal of rejection in human renal homografts with subsequent development of homograft tolerance. Surg. Gynecol. Obstet. 117, 385 (1963).","journal-title":"Surg. Gynecol. Obstet."},{"key":"BFnri1204_CR16","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/00000658-197611000-00006","volume":"184","author":"JE Murray","year":"1976","unstructured":"Murray, J. E., Tilney, N. L. & Wilson, R. E. Renal transplantation: a twenty-five year experience. Ann. Surg. 184, 565\u2013573 (1976).","journal-title":"Ann. Surg."},{"key":"BFnri1204_CR17","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/200702a0","volume":"200","author":"MF Woodruff","year":"1963","unstructured":"Woodruff, M. F. & Anderson, N. F. Effect of lymphocyte depletion by thoracic duct fistula and administration of antilymphocyte serum on the survival of skin homografts in rats. Nature 200, 702 (1963).","journal-title":"Nature"},{"key":"BFnri1204_CR18","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3109\/00365596709133532","volume":"1","author":"C Franksson","year":"1967","unstructured":"Franksson, C. & Bloomstrand, R. Drainage of the thoracic lymph duct during homologous kidney transplantation in man. Scan. J. Urol. Nephrol. 1, 123 (1967).","journal-title":"Scan. J. Urol. Nephrol."},{"key":"BFnri1204_CR19","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1097\/00007890-196609000-00008","volume":"4","author":"HM Abaza","year":"1966","unstructured":"Abaza, H. M., Nolan, B., Watt, J. G. & Woodruff, M. F. Effect of antilymphocytic serum on the survival of renal homotransplants in dogs. Transplantation 4, 618\u2013632 (1966).","journal-title":"Transplantation"},{"key":"BFnri1204_CR20","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1097\/00007890-199904150-00013","volume":"67","author":"DC Brennan","year":"1999","unstructured":"Brennan, D. C. et al. A randomized, double-blinded comparison of thymoglobulin versus atgam for induction immunosuppressive therapy in adult renal transplant recipients. Transplantation 67, 1011\u20131018 (1999).","journal-title":"Transplantation"},{"key":"BFnri1204_CR21","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1097\/00007890-199103000-00024","volume":"51","author":"N Bonnefoy-Berard","year":"1991","unstructured":"Bonnefoy-Berard, N., Vincent, C. & Revillard, J. P. Antibodies against functional leukocyte surface molecules in polyclonal antilymphocyte and antithymocyte globulins. Transplantation 51, 669\u2013673 (1991).","journal-title":"Transplantation"},{"key":"BFnri1204_CR22","first-page":"301","volume":"124","author":"TE Starzl","year":"1967","unstructured":"Starzl, T. E., Marchioro, T. L., Porter, K. A., Iwasaki, Y. & Cerilli, G. J. The use of heterologous antilymphoid agents in canine renal and liver homotransplantation and in human renal homotransplantation. Surg. Gynecol. Obstet. 124, 301\u2013308 (1967).","journal-title":"Surg. Gynecol. Obstet."},{"key":"BFnri1204_CR23","first-page":"197","volume":"29","author":"JS Najarian","year":"1970","unstructured":"Najarian, J. S. et al. Antihuman lymphoblast globulin. Fed. Proc. 29, 197\u2013201 (1970).","journal-title":"Fed. Proc."},{"key":"BFnri1204_CR24","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1097\/00007890-199911270-00032","volume":"68","author":"R Calne","year":"1999","unstructured":"Calne, R. et al. Campath IH allows low-dose cyclosporine monotherapy in 31 cadaveric renal allograft recipients. Transplantation 68, 1613\u20131616 (1999).","journal-title":"Transplantation"},{"key":"BFnri1204_CR25","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/332323a0","volume":"332","author":"L Riechmann","year":"1988","unstructured":"Riechmann, L., Clark, M., Waldmann, H. & Winter, G. Reshaping human antibodies for therapy. Nature 332, 323\u2013327 (1988).","journal-title":"Nature"},{"key":"BFnri1204_CR26","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1034\/j.1600-6143.2003.00042.x","volume":"3","author":"MM Hamawy","year":"2003","unstructured":"Hamawy, M. M., Manthei, E. R., Fechner, J., Hu, H. & Knechtle, S. J. Modulation of TCR function by the anti-CD52 antibody (Campath\u20131H). Am. J. Transplant. 3, 273 (2003).","journal-title":"Am. J. Transplant."},{"key":"BFnri1204_CR27","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/S0140-6736(03)13175-3","volume":"361","author":"TE Starzl","year":"2003","unstructured":"Starzl, T. E. et al. Tolerogenic immunosuppression for organ transplantation. Lancet 361, 1502\u20131510 (2003).","journal-title":"Lancet"},{"key":"BFnri1204_CR28","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1056\/NEJM198108063050603","volume":"305","author":"AB Cosimi","year":"1981","unstructured":"Cosimi, A. B. et al. Use of monoclonal antibodies to T-cell subsets for immunologic monitoring and treatment in recipients of renal allografts. N. Engl. J. Med. 305, 308\u2013314 (1981).","journal-title":"N. Engl. J. Med."},{"key":"BFnri1204_CR29","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/00007890-199901270-00016","volume":"67","author":"BD Kahan","year":"1999","unstructured":"Kahan, B. D., Rajagopalan, P. R. & Hall, M. L. Reduction of the occurrence of acute cellular rejection among renal allograft recipients treated with basiliximab, a chimeric anti-interleukin-2-receptor monoclonal antibody. The United States Simulect\u00ae Renal Study Group. Transplantation 67, 276\u2013284 (1999).","journal-title":"Transplantation"},{"key":"BFnri1204_CR30","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1056\/NEJM199801153380304","volume":"338","author":"F Vincenti","year":"1998","unstructured":"Vincenti, F. et al. Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation. N. Engl. J. Med. 338, 161\u2013165 (1998).","journal-title":"N. Engl. J. Med."},{"key":"BFnri1204_CR31","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1056\/NEJM198912213212507","volume":"321","author":"BD Kahan","year":"1989","unstructured":"Kahan, B. D. Cyclosporine. N. Engl. J. Med. 321, 1725\u20131738 (1989).","journal-title":"N. Engl. J. Med."},{"key":"BFnri1204_CR32","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1097\/00007890-198712000-00002","volume":"44","author":"T Ochiai","year":"1987","unstructured":"Ochiai, T. et al. Studies of the induction and maintenance of long-term graft acceptance by treatment with FK506 in heterotopic cardiac allotransplantation in rats. Transplantation 44, 734\u2013738 (1987).","journal-title":"Transplantation"},{"key":"BFnri1204_CR33","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1097\/00007890-199704150-00013","volume":"63","author":"JD Pirsch","year":"1997","unstructured":"Pirsch, J. D., Miller, J., Deierhoi, M. H., Vincenti, F. & Filo, R. S. A comparison of tacrolimus and cyclosporine for immunosuppression after cadaveric renal transplantation. Transplantation 63, 977\u2013983 (1997).","journal-title":"Transplantation"},{"key":"BFnri1204_CR34","doi-asserted-by":"crossref","first-page":"18325","DOI":"10.1074\/jbc.273.29.18325","volume":"273","author":"MM Lai","year":"1998","unstructured":"Lai, M. M., Burnett, P. E., Wolosker, H., Blackshaw, S. & Snyder, S. H. Cain, a novel physiologic protein inhibitor of calcineurin. J. Biol. Chem. 273, 18325\u201318331 (1998).","journal-title":"J. Biol. Chem."},{"key":"BFnri1204_CR35","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/S0041-1345(03)00211-2","volume":"35","author":"SN Sehgal","year":"2003","unstructured":"Sehgal, S. N. Sirolimus: its discovery, biological properties, and mechanism of action. Transplant Proc. 35, S7\u2013S14 (2003).","journal-title":"Transplant Proc."},{"key":"BFnri1204_CR36","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1097\/00007890-200105270-00008","volume":"71","author":"BD Kahan","year":"2001","unstructured":"Kahan, B. D. et al. RAD in de novo renal transplantation: comparison of three doses on the incidence and severity of acute rejection. Transplantation 71, 1400\u20131406 (2001).","journal-title":"Transplantation"},{"key":"BFnri1204_CR37","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/S0041-1345(03)00351-8","volume":"35","author":"BD Kahan","year":"2003","unstructured":"Kahan, B. D. et al. Ten years of sirolimus therapy for human renal transplantation: the University of Texas at Houston experience. Transplant Proc. 35, S25\u2013S34 (2003).","journal-title":"Transplant Proc."},{"key":"BFnri1204_CR38","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/00007890-200301150-00025","volume":"75","author":"P Monti","year":"2003","unstructured":"Monti, P. et al. Rapamycin impairs antigen uptake of human dendritic cells. Transplantation 75, 137\u2013145 (2003).","journal-title":"Transplantation"},{"key":"BFnri1204_CR39","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S0887-7963(05)80079-3","volume":"9","author":"A Fletcher","year":"1995","unstructured":"Fletcher, A. & Thomson, A. The introduction of human monoclonal anti-D for therapeutic use. Transfus. Med. Rev. 9, 314\u2013326 (1995).","journal-title":"Transfus. Med. Rev."},{"key":"BFnri1204_CR40","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1056\/NEJMra993360","volume":"345","author":"MD Kazatchkine","year":"2001","unstructured":"Kazatchkine, M. D. & Kaveri, S. V. Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin. N. Engl. J. Med. 345, 747\u2013755 (2001).","journal-title":"N. Engl. J. Med."},{"key":"BFnri1204_CR41","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1034\/j.1600-6143.2002.20801.x","volume":"2","author":"SC Jordan","year":"2002","unstructured":"Jordan, S. C. Management of the highly HLA-sensitized patient. A novel role for intravenous gammaglobulin. Am. J. Transplant. 2, 691\u2013692 (2002).","journal-title":"Am. J. Transplant."},{"key":"BFnri1204_CR42","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1097\/00007890-200009270-00006","volume":"70","author":"RA Montgomery","year":"2000","unstructured":"Montgomery, R. A. et al. Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients. Transplantation 70, 887\u2013895 (2000).","journal-title":"Transplantation"},{"key":"BFnri1204_CR43","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/00007890-200201150-00019","volume":"73","author":"EA Verschuuren","year":"2002","unstructured":"Verschuuren, E. A. et al. Treatment of posttransplant lymphoproliferative disease with rituximab: the remission, the relapse, and the complication. Transplantation 73, 100\u2013104 (2002).","journal-title":"Transplantation"},{"key":"BFnri1204_CR44","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1097\/00007890-200203270-00013","volume":"73","author":"JMJr Aranda","year":"2002","unstructured":"Aranda, J. M. Jr. et al. Anti-CD20 monoclonal antibody (rituximab) therapy for acute cardiac humoral rejection: a case report. Transplantation 73, 907\u2013910 (2002).","journal-title":"Transplantation"},{"key":"BFnri1204_CR45","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0952-7915(00)00130-8","volume":"12","author":"WW Hancock","year":"2000","unstructured":"Hancock, W. W., Gao, W., Faia, K. L. & Csizmadia, V. Chemokines and their receptors in allograft rejection. Curr. Opin. Immunol. 12, 511\u2013516 (2000).","journal-title":"Curr. Opin. Immunol."},{"key":"BFnri1204_CR46","first-page":"881","volume":"17","author":"M Azzawi","year":"1998","unstructured":"Azzawi, M. et al. RANTES chemokine expression is related to acute cardiac cellular rejection and infiltration by CD45RO T-lymphocytes and macrophages. J. Heart Lung Transplant. 17, 881\u2013887 (1998).","journal-title":"J. Heart Lung Transplant."},{"key":"BFnri1204_CR47","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s002280000166","volume":"56","author":"LP Rivory","year":"2000","unstructured":"Rivory, L. P. et al. Frequency of cytochrome P450 3A4 variant genotype in transplant population and lack of association with cyclosporin clearance. Eur. J. Clin. Pharmacol. 56, 395\u2013398 (2000).","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"BFnri1204_CR48","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1124\/jpet.102.044719","volume":"305","author":"CL Cummins","year":"2003","unstructured":"Cummins, C. L., Salphati, L., Reid, M. J. & Benet, L. Z. In vivo modulation of intestinal CYP3A metabolism by P-glycoprotein: studies using the rat single-pass intestinal perfusion model. J. Pharmacol. Exp. Ther. 305, 306\u2013314 (2003).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BFnri1204_CR49","first-page":"131","volume":"18","author":"MF Woodruff","year":"1959","unstructured":"Woodruff, M. F. Evidence of adaptation in homografts of normal tissue. Bull. Soc. Internat. Chir. Brux. 18, 131\u2013138 (1959).","journal-title":"Bull. Soc. Internat. Chir. Brux."},{"key":"BFnri1204_CR50","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1053\/rr.2000.5269","volume":"7","author":"I Penn","year":"2000","unstructured":"Penn, I. Cancers in renal transplant recipients. Adv. Ren. Replace. Ther. 7, 147\u2013156 (2000).","journal-title":"Adv. Ren. Replace. Ther."},{"key":"BFnri1204_CR51","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1097\/01.ASN.0000023435.07320.81","volume":"13","author":"E Ramos","year":"2002","unstructured":"Ramos, E. et al. Clinical course of polyoma virus nephropathy in 67 renal transplant patients. J. Am. Soc. Nephrol. 13, 2145\u20132151 (2002).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnri1204_CR52","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1034\/j.1399-3062.2001.003001008.x","volume":"3","author":"A Lo","year":"2001","unstructured":"Lo, A. et al. Patterns of cytomegalovirus infection in simultaneous kidney-pancreas transplant recipients receiving tacrolimus, mycophenolate mofetil, and prednisone with ganciclovir prophylaxis. Transpl. Infect. Dis. 3, 8\u201315 (2001).","journal-title":"Transpl. Infect. Dis."},{"key":"BFnri1204_CR53","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1097\/00007890-199911270-00016","volume":"68","author":"BD Kahan","year":"1999","unstructured":"Kahan, B. D. et al. Sirolimus reduces the incidence of acute rejection episodes despite lower cyclosporine doses in Caucasian recipients of mismatched primary renal allografts: a phase II trial. Transplantation 68, 1526\u20131532 (1999).","journal-title":"Transplantation"},{"key":"BFnri1204_CR54","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1034\/j.1600-6143.2001.10407.x","volume":"1","author":"L Kung","year":"2001","unstructured":"Kung, L. et al. Tissue distribution of calcineurin and its sensitivity to inhibition by cyclosporine. Am. J. Transplant. 1, 325\u2013333 (2001).","journal-title":"Am. J. Transplant."},{"key":"BFnri1204_CR55","doi-asserted-by":"crossref","first-page":"28181","DOI":"10.1016\/S0021-9258(18)46911-6","volume":"269","author":"AM Ho","year":"1994","unstructured":"Ho, A. M., Jain, J., Rao, A. & Hogan, P. G. Expression of the transcription factor NFATp in a neuronal cell line and in the murine nervous system. J. Biol. Chem. 269, 28181\u201328186 (1994).","journal-title":"J. Biol. Chem."},{"key":"BFnri1204_CR56","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/1097-4644(20001201)79:3<427::AID-JCB80>3.0.CO;2-0","volume":"79","author":"PT Pham","year":"2000","unstructured":"Pham, P. T. et al. Assessment of cell-signaling pathways in the regulation of mammalian target of rapamycin (mTOR) by amino acids in rat adipocytes. J. Cell. Biochem. 79, 427\u2013441 (2000).","journal-title":"J. Cell. Biochem."},{"key":"BFnri1204_CR57","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/00075200-200009000-00016","volume":"5","author":"K Mahalati","year":"2000","unstructured":"Mahalati, K. & Kahan, B. D. Advancing the art of immunosuppression with the science of pharmacology. Curr. Opin. Organ Transplant. 5, 255\u2013262 (2000).","journal-title":"Curr. Opin. Organ Transplant."},{"key":"BFnri1204_CR58","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1067\/mcp.2001.116309","volume":"70","author":"BD Kahan","year":"2001","unstructured":"Kahan, B. D. & Kramer, W. G. Median effect analysis of efficacy versus adverse effects of immunosuppressants. Clin. Pharmacol. Ther. 70, 74\u201381 (2001).","journal-title":"Clin. Pharmacol. Ther."},{"key":"BFnri1204_CR59","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1097\/00007890-199908270-00006","volume":"68","author":"TR Spitzer","year":"1999","unstructured":"Spitzer, T. R. et al. Combined histocompatibility leukocyte antigen-matched donor bone marrow and renal transplantation for multiple myeloma with end stage renal disease: the induction of allograft tolerance through mixed lymphohematopoietic chimerism. Transplantation 68, 480\u2013484 (1999).","journal-title":"Transplantation"},{"key":"BFnri1204_CR60","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1126\/science.270.5239.1189","volume":"270","author":"TS Griffith","year":"1995","unstructured":"Griffith, T. S., Brunner, T., Fletcher, S. M., Green, D. R. & Ferguson, T. A. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 270, 1189\u20131192 (1995).","journal-title":"Science"},{"key":"BFnri1204_CR61","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1146\/annurev.immunol.17.1.221","volume":"17","author":"M Lenardo","year":"1999","unstructured":"Lenardo, M. et al. Mature T lymphocyte apoptosis \u2014 immune regulation in a dynamic and unpredictable antigenic environment. Annu. Rev. Immunol. 17, 221\u2013253 (1999).","journal-title":"Annu. Rev. Immunol."},{"key":"BFnri1204_CR62","unstructured":"Kahan, B. D. et al. Safety and tolerability of multiple doses of FTY720 in stable renal transplant patients. Transplantation (in the press)."},{"key":"BFnri1204_CR63","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1097\/00007890-200109150-00002","volume":"72","author":"V Brinkmann","year":"2001","unstructured":"Brinkmann, V., Pinschewer, D. D., Feng, L. & Chen, S. FTY720: altered lymphocyte traffic results in allograft protection. Transplantation 72, 764\u2013769 (2001).","journal-title":"Transplantation"},{"key":"BFnri1204_CR64","doi-asserted-by":"crossref","first-page":"11830","DOI":"10.1074\/jbc.M009422200","volume":"276","author":"JH Paik","year":"2001","unstructured":"Paik, J. H., Chae, S. S., Lee, M. J., Thangada, S. & Hla, T. Sphingosine 1-phosphate-induced endothelial cell migration requires the expression of EDG-1 and EDG-3 receptors and Rho-dependent activation of \u03b1v\u03b23- and \u03b21-containing integrins. J. Biol. Chem. 276, 11830\u201311837 (2001).","journal-title":"J. Biol. Chem."},{"key":"BFnri1204_CR65","first-page":"194","volume":"3","author":"AE Gelman","year":"2003","unstructured":"Gelman, A. E. & Turka, L. E. A novel role for toll like receptor 4: inhibition of TNF\u03b1 induced dendritic cell maturation. Am. J. Transplant. 3, 194 (2003).","journal-title":"Am. J. Transplant."},{"key":"BFnri1204_CR66","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1034\/j.1600-6143.2003.00064.x","volume":"3","author":"SS Pendse","year":"2003","unstructured":"Pendse, S. S., Behjati, S., Sayegh, M. H. & Frank, M. H. MDR1 P-glycoprotein is a dendritic cell\/macrophage differentiation switch in antigen presenting cell maturation. Am. J. Transplant. 3, 340 (2003).","journal-title":"Am. J. Transplant."},{"key":"BFnri1204_CR67","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1084\/jem.20021598","volume":"196","author":"L Bonifaz","year":"2002","unstructured":"Bonifaz, L. et al. Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance. J. Exp. Med. 196, 1627\u20131638 (2002).","journal-title":"J. Exp. Med."},{"key":"BFnri1204_CR68","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1046\/j.1440-1711.2002.01114.x","volume":"80","author":"AG Thompson","year":"2002","unstructured":"Thompson, A. G. & Thomas, R. Induction of immune tolerance by dendritic cells: implications for preventative and therapeutic immunotherapy of autoimmune disease. Immunol. Cell Biol. 80, 509\u2013519 (2002).","journal-title":"Immunol. Cell Biol."},{"key":"BFnri1204_CR69","doi-asserted-by":"crossref","first-page":"S113","DOI":"10.1067\/mai.2000.106057","volume":"106","author":"S Strober","year":"2000","unstructured":"Strober, S. Natural killer 1. 1+ T cells and 'natural suppressor' T cells in the bone marrow. J. Allergy Clin. Immunol. 106, S113\u2013S114 (2000).","journal-title":"J. Allergy Clin. Immunol."},{"key":"BFnri1204_CR70","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/nm0202-171","volume":"8","author":"F Fandrich","year":"2002","unstructured":"Fandrich, F. et al. Preimplantation-stage stem cells induce long-term allogeneic graft acceptance without supplementary host conditioning. Nature Med. 8, 171\u2013178 (2002).","journal-title":"Nature Med."},{"key":"BFnri1204_CR71","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1097\/01.ASN.0000076844.59963.CF","volume":"14","author":"F Vincenti","year":"2003","unstructured":"Vincenti, F. Immunosuppression minimization: current and future trends in transplant immunosuppression. J. Am. Soc. Nephrol. 14, 1940\u20131948 (2003).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnri1204_CR72","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/ijc.10576","volume":"101","author":"MR Shurin","year":"2002","unstructured":"Shurin, M. R., Yurkovetsky, Z. R., Tourkova, I. L., Balkir, L. & Shurin, G. V. Inhibition of CD40 expression and CD40-mediated dendritic cell function by tumor-derived IL-10. Int. J. Cancer 101, 61\u201368 (2002).","journal-title":"Int. J. Cancer"},{"key":"BFnri1204_CR73","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/9536","volume":"5","author":"AD Kirk","year":"1999","unstructured":"Kirk, A. D. et al. Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates. Nature Med. 5, 686\u2013693 (1999).","journal-title":"Nature Med."},{"key":"BFnri1204_CR74","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJM199806183382506","volume":"338","author":"MH Sayegh","year":"1998","unstructured":"Sayegh, M. H. & Turka, L. A. The role of T-cell co-stimulatory activation pathways in transplant rejection. N. Engl. J. Med. 338, 1813\u20131821 (1998).","journal-title":"N. Engl. J. Med."},{"key":"BFnri1204_CR75","doi-asserted-by":"crossref","first-page":"633","DOI":"10.4049\/jimmunol.169.2.633","volume":"169","author":"KW Hwang","year":"2002","unstructured":"Hwang, K. W. et al. Cutting edge: targeted ligation of CTLA-4 in vivo by membrane-bound anti-CTLA-4 antibody prevents rejection of allogeneic cells. J. Immunol. 169, 633\u2013637 (2002).","journal-title":"J. Immunol."},{"key":"BFnri1204_CR76","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1146\/annurev.immunol.19.1.565","volume":"19","author":"CA Chambers","year":"2001","unstructured":"Chambers, C. A., Kuhns, M. S., Egen, J. G. & Allison, J. P. CTLA-4-mediated inhibition in regulation of T cell responses: mechanisms and manipulation in tumor immunotherapy. Annu. Rev. Immunol. 19, 565\u2013594 (2001).","journal-title":"Annu. Rev. Immunol."},{"key":"BFnri1204_CR77","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1046\/j.1600-6143.2003.00220.X","volume":"3","author":"SE Sandner","year":"2003","unstructured":"Sandner, S. E. et al. Functions of the regulatory T cell co-stimulatory pathways CTLA-4 and PD-1 in alloreactive CD4+ T cell responses in vivo. Am. J. Transplant. 3, 152 (2003).","journal-title":"Am. J. Transplant."},{"key":"BFnri1204_CR78","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1097\/00007890-199705270-00001","volume":"63","author":"M Wang","year":"1997","unstructured":"Wang, M., Stepkowski, S. M., Yu, J., Wang, M. & Kahan, B. D. Localization of cryptic tolerogenic epitopes in the \u03b11-helical region of the RT1. Au alloantigen. Transplantation 63, 1373\u20131379 (1997).","journal-title":"Transplantation"},{"key":"BFnri1204_CR79","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S1074-7613(00)00052-2","volume":"13","author":"JE Slansky","year":"2000","unstructured":"Slansky, J. E. et al. Enhanced antigen-specific antitumor immunity with altered peptide ligands that stabilize the MHC\u2013peptide\u2013TCR complex. Immunity 13, 529\u2013538 (2000).","journal-title":"Immunity"},{"key":"BFnri1204_CR80","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/S0041-1345(02)02909-3","volume":"34","author":"W Waegell","year":"2002","unstructured":"Waegell, W. et al. A420983, a novel small molecule inhibitor of lck prevents allograft rejection. Transplant Proc. 34, 1411\u20131417 (2002).","journal-title":"Transplant Proc."},{"key":"BFnri1204_CR81","first-page":"305","volume":"3","author":"ME Wang","year":"2003","unstructured":"Wang, M. E., Stepkowski, S. M., Kirken, R., Dimmock, J. & Kahan, B. D. In vivo immunosuppressive effects of NC1153, a novel selective janus tyrosine kinase (Jak 3) antagonist. Am. J. Transplant. 3, 305 (2003).","journal-title":"Am. J. Transplant."},{"key":"BFnri1204_CR82","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nri774","volume":"2","author":"DM Pardoll","year":"2002","unstructured":"Pardoll, D. M. Spinning molecular immunology into successful immunotherapy. Nature Rev. Immunol. 2, 227\u2013238 (2002).","journal-title":"Nature Rev. Immunol."},{"key":"BFnri1204_CR83","first-page":"105","volume":"14","author":"TA Waldmann","year":"2001","unstructured":"Waldmann, T. A., Dubois, S. & Tagaya, Y. Contrasting roles of IL-2 and IL-15 in the life and death of lymphocytes: implications for immunotherapy. Immunity 14, 105\u2013110 (2001).","journal-title":"Immunity"},{"key":"BFnri1204_CR84","doi-asserted-by":"crossref","first-page":"3444","DOI":"10.4049\/jimmunol.165.6.3444","volume":"165","author":"XG Smith","year":"2000","unstructured":"Smith, X. G. et al. Selective blockade of IL-15 by soluble IL-15 receptor \u03b1-chain enhances cardiac allograft survival. J. Immunol. 165, 3444\u20133450 (2000).","journal-title":"J. Immunol."},{"key":"BFnri1204_CR85","first-page":"205","volume":"9","author":"GL Asherson","year":"1965","unstructured":"Asherson, G. L. & Stone, S. H. Selective and specific inhibition of 24 hour skin reactions in the guinea-pig. I. Immune deviation: description of the phenomenon and the effect of splenectomy. Immunol. 9, 205\u2013217 (1965).","journal-title":"Immunol."},{"key":"BFnri1204_CR86","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S1246-7820(01)00122-7","volume":"8","author":"FH Claas","year":"2001","unstructured":"Claas, F. H., Roelen, D. L., van Rood, J. J. & Brand, A. Modulation of the alloimmune response by blood transfusions. Transfus. Clin. Biol. 8, 315\u2013317 (2001).","journal-title":"Transfus. Clin. Biol."},{"key":"BFnri1204_CR87","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1034\/j.1600-6143.2003.00124.x","volume":"3","author":"S Jiang","year":"2003","unstructured":"Jiang, S. & Lechler, R. I. Regulatory T cells in the control of transplantation tolerance and autoimmunity. Am. J. Transplant. 3, 516\u2013524 (2003).","journal-title":"Am. J. Transplant."},{"key":"BFnri1204_CR88","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/ni909","volume":"4","author":"R Khattri","year":"2003","unstructured":"Khattri, R., Cox, T., Yasayko, S. A. & Ramsdell, F. An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nature Immunol. 4, 337\u2013342 (2003).","journal-title":"Nature Immunol."},{"key":"BFnri1204_CR89","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1084\/jem.191.6.985","volume":"191","author":"S Li","year":"2000","unstructured":"Li, S. et al. Cytokine-induced Src homology 2 protein (CIS) promotes T cell receptor-mediated proliferation and prolongs survival of activated T cells. J. Exp. Med. 191, 985\u2013994 (2000).","journal-title":"J. Exp. Med."},{"key":"BFnri1204_CR90","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1146\/annurev.immunol.18.1.143","volume":"18","author":"H Yasukawa","year":"2000","unstructured":"Yasukawa, H., Sasaki A & Yoshimura A. Negative regulation of cytokine signaling pathways. Annu. Rev. Immunol. 18, 143\u2013164 (2000).","journal-title":"Annu. Rev. Immunol."},{"key":"BFnri1204_CR91","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/S0140-6736(78)91970-0","volume":"2","author":"RY Calne","year":"1978","unstructured":"Calne, R. Y. et al. Cyclosporin A in patients receiving renal allografts from cadaver donors. Lancet 2, 1323\u20131327 (1978).","journal-title":"Lancet"},{"key":"BFnri1204_CR92","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0140-6736(00)02480-6","volume":"356","author":"BD Kahan","year":"2000","unstructured":"Kahan, B. D. Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study. For the Rapamune U. S. Study Group. Lancet 356, 194\u2013202 (2000).","journal-title":"Lancet"}],"container-title":["Nature Reviews Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nri1204.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nri1204","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nri1204.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T04:04:39Z","timestamp":1684469079000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nri1204"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,10]]},"references-count":92,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2003,10]]}},"alternative-id":["BFnri1204"],"URL":"https:\/\/doi.org\/10.1038\/nri1204","relation":{},"ISSN":["1474-1733","1474-1741"],"issn-type":[{"value":"1474-1733","type":"print"},{"value":"1474-1741","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,10]]}}}